Trial Profile
Impact of HCV RNA levels on final treatment outcome in hepatitis C infected patients treated with sofosbuvir-based therapies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Apr 2016
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Daclatasvir; Peginterferon alfa; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Therapeutic Use
- 13 Apr 2016 Results published in the Journal of Hepatology
- 19 Aug 2015 New trial record